Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.094312 | 0.414048 | 0.414048 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0145871 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0145871 | 0 | 0.5 |
Leishmania major | dihydroorotate dehydrogenase | 0.0165143 | 0.0100088 | 1 |
Mycobacterium leprae | Probable dihydroorotate dehydrogenase PyrD | 0.0165143 | 0.0100088 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.207137 | 1 | 1 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0145871 | 0 | 0.5 |
Mycobacterium ulcerans | dihydroorotate dehydrogenase 2 | 0.0165143 | 0.0100088 | 0.0100088 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0145871 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0145871 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.094312 | 0.414048 | 1 |
Toxoplasma gondii | dihydroorotate dehydrogenase reveal, putative | 0.0165143 | 0.0100088 | 1 |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0165143 | 0.0100088 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0145871 | 0 | 0.5 |
Plasmodium falciparum | dihydroorotate dehydrogenase | 0.0165143 | 0.0100088 | 0.0241731 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.094312 | 0.414048 | 0.414048 |
Loa Loa (eye worm) | hypothetical protein | 0.0145871 | 0 | 0.5 |
Trypanosoma cruzi | dihydroorotate dehydrogenase (fumarate), putative | 0.0165143 | 0.0100088 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0145871 | 0 | 0.5 |
Trypanosoma brucei | dihydroorotate dehydrogenase (fumarate) | 0.0165143 | 0.0100088 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.094312 | 0.414048 | 0.414048 |
Echinococcus multilocularis | 0.0145871 | 0 | 0.5 | |
Trypanosoma cruzi | dihydroorotate dehydrogenase, putative | 0.0165143 | 0.0100088 | 1 |
Schistosoma mansoni | dihydroorotate dehydrogenase | 0.0165143 | 0.0100088 | 1 |
Onchocerca volvulus | 0.0145871 | 0 | 0.5 | |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0165143 | 0.0100088 | 1 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.207137 | 1 | 1 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.094312 | 0.414048 | 0.447987 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.094312 | 0.414048 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0145871 | 0 | 0.5 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.094312 | 0.414048 | 1 |
Brugia malayi | Dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0165143 | 0.0100088 | 1 |
Mycobacterium tuberculosis | Probable flavin-containing monoamine oxidase AofH (amine oxidase) (MAO) | 0.19255 | 0.924242 | 1 |
Plasmodium vivax | dihydroorotate dehydrogenase, mitochondrial precursor, putative | 0.0165143 | 0.0100088 | 0.0241731 |
Mycobacterium tuberculosis | Probable dihydroorotate dehydrogenase PyrD | 0.0165143 | 0.0100088 | 0.0108292 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.094312 | 0.414048 | 1 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0145871 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (functional) | = 0.0342 ng ml-1 | Compound was tested in vitro for antimalarial activity against W-2 strain (Plasmodium falciparum) | ChEMBL. | 11689078 |
IC90 (functional) | = 0.32 ng ml-1 | In vitro for antimalarial activity against K-1 strain (Plasmodium falciparum) | ChEMBL. | 11689078 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 11689078 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.